Last week was not a great one for Hillary Clinton on the campaign trail, or for the stocks that might benefit from her presidency.
The Democratic Party presidential nominee started the week with a slew of bad headlines. After falling ill at a 9/11 commemoration ceremony, Clinton was revealed to have been diagnosed with pneumonia and subsequently took a few days off from campaigning. She continued to take heat for referring to some of her rival Donald Trump's supporters as a "basket of deplorables," walking back not the sentiment but instead her use of the word "half."
Clinton's lead also continued to shrink in the polls. According to a RealClearPolitics average, her lead over Trump is now just 0.9%.
The Hillary Clinton Stock Portfolio, a set of 15 stocks Clinton has identified that could do well with Clinton in the White House, had a rather unremarkable week. From market close Friday, September 9 to market close Friday, September 16, the portfolio fell by 0.38%. (Our Donald Trump Stock Portfolio fell by 1.68%).
Since we began tracking the portfolio in late July, the Clinton portfolio has declined by 6.09%; the Trump portfolio by 8.53%.
SolarCity (SCTY) was the top performer in the Clinton portfolio last week. Its price climbed 4.35% to $17.50 at market close Friday. Last week, the company said it had raised $305 million in a cash equity transaction, and Nevada regulators approved a deal between Berkshire Hathaway's (BRK.A) - Get Report(BRK.B) - Get Report NV Energy and SolarCity to roll back rate hikes for existing rooftop solar customers. Bloomberg noted on Monday that an impending merger between SolarCity and Tesla (TSLA) - Get Reportcould be delayed by shareholder lawsuits.
Shares of Walmart (WMT) - Get Report rallied 3.66% to $72.87. Analysts at Credit Suisse Friday upgraded their rating on the retailer to outperform and set their price target at $80. TheStreet's Jim Cramer said the move was "a good call."
Netflix (NFLX) - Get Report climbed 3.09%, trading at market close Friday at $99.48. The streaming video company hasn't exactly been hitting home runs lately, with two consecutive lackluster quarters dragging down its stock price. But there are reasons to be optimistic about the company's profitability thanks to subscriber and viewership trends, wrote RBC Capital Markets in a note last week.
U.S. Steel (X) - Get Report was the biggest drag on the Clinton portfolio last week. Its price fell 6.58% to $15.91. The U.S. International Trade Commission last week affirmed anti-dumping and anti-subsidy duties on hot-rolled flat steel imports from seven countries, and the U.S. Commerce Department levied anti-dumping and anti-subsidy duties on certain Chinese products -- both of which should have been good news for U.S. Steel, but the stock price dropped anyway. Shares of the company are down more than 25% over the past month, but on Monday, KeyBanc Capital Markets raised its rating on the stock.
Here's how the entire Clinton portfolio did last week, leading with the top gainers:
Aetna (AET) -0.42%
Smith & Wesson (SWHC) -0.76%
U.S. Steel -6.58%